CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors
Therapy resistance is a significant concern while treating malignant disease. Accumulating evidence suggests that a subset of cancer cells potentiates tumor survival, therapy resistance, and relapse. Several different pathways regulate these purported cancer stem cells (CSCs). Evidence shows that th...
Main Authors: | Caitlin Molczyk, Rakesh K. Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/2/576 |
Similar Items
-
A Study of CD4, CCR3, CCR4, CCR5, CXCR3 Expression in Peripheral Blood Lymphocytes of Patients with Gastric Cancer
by: Alireza Andalib, et al.
Published: (2012-03-01) -
Targeting G protein-coupled receptor for pain management
by: Hongyan Li, et al.
Published: (2017-01-01) -
CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
by: Xinxin Huang, et al.
Published: (2022-02-01) -
Evolutionarily conserved mechanisms regulating stress-induced neutrophil redistribution in fish
by: Katarzyna Klak, et al.
Published: (2024-03-01) -
Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
by: Zhi-Jian Han, et al.
Published: (2021-12-01)